UPC (Universe Pharmaceuticals) Research & Development: $0.67 Mil (TTM As of Sep. 2025)


UPC Universe Pharmaceuticals Inc UPC
58 GF Score
Price $2.77
GF Value $5.22
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Research & Development?

Universe Pharmaceuticals UPC -2.81% 58 Research & Development is $0.67 Mil as of Sep. 2025. GuruFocus rates UPC with a GF Score™ of 58/100 and a GF Value™ of $5.22 (Possible Value Trap). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Universe Pharmaceuticals's Research & Development for the six months ended in Sep. 2025 was $0.58 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was $0.67 Mil.

Universe Pharmaceuticals  (NAS:UPC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Universe Pharmaceuticals Research & Development Related Terms

Universe Pharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Research & Development Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial 5.47 7.64 4.86 3.60 0.67

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.59 0.09 3.51 0.10 0.58
UPC
58GF Score
Universe Pharmaceuticals Inc UPC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universe Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.67 Mil mean?
Universe Pharmaceuticals (UPC) has a Research & Development of $0.67 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Research & Development too high?
Universe Pharmaceuticals' current Research & Development is $0.67 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Research & Development compare to CBIH and PRFX?
Universe Pharmaceuticals' Research & Development of $0.67 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Research & Development is $0.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Possible Value Trap. The stock's GF Value™ is $5.22, compared to a current price of $2.77 — trading 46.9% below its estimated fair value. The current Research & Development is $0.67 Mil. Universe Pharmaceuticals' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Research & Development is $0.67 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued. The current stock price of $2.77 is trading 46.9% below its estimated GF Value™ of $5.22. GuruFocus considers Universe Pharmaceuticals to be Possible Value Trap.

Key valuation signals for UPC:

  • Research & Development: $0.67 Mil
  • GF Value™: $5.22 vs. price of $2.77 (46.9% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
58GF Score

Get the complete analysis for UPC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77
Price
$5.22
GF Value